Skip to content

Drug interactions

Meningococcal group b vaccine + Topotecan

Severity: Moderate

Meningococcal group b vaccine and Topotecan: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Topotecan causes myelosuppression and impaired immune function, which can blunt the antibody response to inactivated vaccines such as meningococcal B. Patients may therefore have inadequate protection despite vaccination.

What this interaction means in plain words

Meningococcal group b vaccine and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Moderate

Why it happens

Cytotoxic chemotherapy suppresses lymphocyte function and so reduces vaccine immunogenicity.

What to do

Where feasible, vaccinate at least 2 weeks before starting chemotherapy or delay until immune recovery after the cycle. Do not regard vaccination during chemotherapy as reliably protective, and revaccinate if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Meningococcal group b vaccine and Topotecan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Meningococcal group b vaccine with Topotecan?

MediHelp rates the interaction as moderate. Meningococcal group b vaccine and Topotecan can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Topotecan causes myelosuppression and impaired immune function, which can blunt the antibody response to inactivated vaccines such as meningococcal B. Patients may therefore have inadequate protection despite vaccination.

How serious is the interaction between Meningococcal group b vaccine and Topotecan?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Where feasible, vaccinate at least 2 weeks before starting chemotherapy or delay until immune recovery after the cycle. Do not regard vaccination during chemotherapy as reliably protective, and revaccinate if needed.

What other medicines interact with Topotecan?

MediHelp also lists interactions of Topotecan with, for example, Adenovirus types 4 and 7 live, Amiodarone, Cisplatin. The full list is on the Topotecan page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in